Evidence map›Paper›PMID 36328739›Full record

ArticleJournal of advanced research2022

The ubiquitin-specific protease 8 antagonizes melatonin-induced endocytic degradation of MT

Qianhui Sun, Jinrui Zhang, Xiaoxi Li, Guoheng Yang, Shaoxuan Cheng, Dong Guo, Qingqing Zhang, Feng Sun, Feng Zhao, Dian Yang and 6 more

Open access · goldAbstract read
In one paragraph

Article in Journal of advanced research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Qianhui SunSecond Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China; Clinical Laboratory, The Third People's Hospital of Dalian, Dalian Medical University, Dalian, China.
Jinrui ZhangSecond Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
Xiaoxi LiCentral Laboratory, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, China.
Guoheng YangSecond Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
Shaoxuan ChengSecond Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
Dong GuoSecond Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
Qingqing ZhangDepartment of Pathology, College of Basic Medical Sciences, Dalian Medical University, Dalian, China.
Feng SunCollege of Life Science, Liaoning Normal University, Dalian, China.
Feng ZhaoDepartment of Cell Biology, College of Basic Medical Sciences, Dalian Medical University, Dalian, China.
Dian YangSecond Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
Shanshan WangSecond Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
Taishu WangSecond Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
Shuyan LiuSecond Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
Lijuan ZouSecond Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China. Electronic address: zoulijuan1963@sina.com.
Yingqiu ZhangSecond Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China. Electronic address: zhangyingqiu.no.1@163.com.
Han LiuSecond Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China. Electronic address: liuhan@dmu.edu.cn.
Dalian Medical University · CNSecond Affiliated Hospital of Dalian Medical University · CNLiaoning Cancer Hospital & Institute · CNLiaoning Normal University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe human genome encodes two melatonin receptors (MT

objectivesThis study aims to investigate the response of the MT

methodsThe mRNA levels of MT

resultsBioinformatic analysis revealed increased expression of the MT

conclusionThe MT

Indexed as

AdenocarcinomaAdenocarcinoma of LungLung NeoplasmsMelatoninAnimalsHumansReceptor, Melatonin, MT1Receptor, Melatonin, MT2Ubiquitin-Specific ProteasesMelatoninReceptor, Melatonin, MT1Receptor, Melatonin, MT2Ubiquitin-Specific ProteasesDUBEndocytosisLung adenocarcinomaMelatoninMT(1)USP8

Identifiers

PMID36328739
PMCPMC9637587
OpenAlexW4210578717

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.